SBIR-STTR Award

Amplified Card Immunoassay For Drugs In Saliva
Award last edited on: 4/26/02

Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$100,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Allen G Beard

Company Information

Amplistar (AKA: Elcatech Inc)

101 North Chestnut Street Suite 203
Winston-Salem, NC 27106
   (336) 777-3624
   klogan@amplistar.com
   www.amplistar.com
Location: Single
Congr. District: 05
County: Forsyth

Phase I

Contract Number: 1R43GM057096-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1998
Phase I Amount
$100,000
A new technique for amplified immunoassay will be developed for measurement of drugs of abuse in saliva specimens. It uses the coagulation cascade with a snake venom activator (Russell's Viper venom factor X activator, RVV-XA) as a labeling enzyme to label antibodies reactive with THC, cocaine/benzoylecgonine, opiates or amphetamines/methamphetamines in an immunochromatography format (ELISA). Coagulation activity is measured using colored microbeads coated with fibrinogen and solid-phase, immobile fibrinogen (enzyme-linked coagulation assay, or ELCA). The combination of immunochromatography with coagulation-based detection, known as ELISA-ELCA will be accomplished in a user-friendly 'card' format yielding a color-test indication of the presence of drugs at defined cutoff values. The test system will be developed to allow determination of drug levels appropriate to measure intoxication by testing diluted saliva. The appropriate sensitivity will be determined by using human subjects who are regular marijuana users being administered THC in a controlled performance-evaluation protocol. Mouth swabs will be obtained from each subject at the time the performance test, and several hours later when they are administered a sobriety test. For other drugs, saliva levels will be compared with blood and urine levels in rats currently being used to study THC, cocaine and amphetamine intoxication. At the end of this project, we will have developed a new test system which will yield usable cards capable of identifying individuals with saliva levels of drugs of abuse consistent with intoxication and methods for measuring trace levels of drugs to evaluate long-term abuse. PROPOSED COMMERCIAL APPLICATION The detection of drugs of abuse in saliva will have the advantage of a less invasive test system which in the proposed format will not be much more difficult than the current 'breathalyzer' tests used to detect alcohol abuse..

Thesaurus Terms:
colorimetry, diagnosis design /evaluation, drug abuse, drug testing, immunologic assay /test, saliva Cannabis, amphetamine, antibody, chromatography, cocaine, enzyme linked immunosorbent assay, fibrinogen, morphine, ultrafiltration behavior test, clinical research, human subject, laboratory rat, performance

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----